Wells Fargo & Company »

Quince Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Quince Therapeutics shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Quince Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Quince Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Quince Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $182 10 18.20

More positions owned by Wells Fargo & Company

Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
NVIDIA Corporation Put Option (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
JPMorgan Chase & Co. (JPM)
Ishares Core Msci Emkt (IEMG)

View all positions for Wells Fargo & Company

Top funds holding Quince Therapeutics

Tudor Investment Corporation
Ikarian Capital
Millennium Management
Balyasny Asset Management
Susquehanna International
Squadron Capital Management
Shay Capital
Boothbay Fund Management
Jane Street
Vanguard Capital Management
Cormorant Asset Management
UBS Group
Vanguard Fiduciary Trust
BlackRock
Tower Research Capital

View all funds holding Quince Therapeutics